XML 48 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-based compensation - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
May 31, 2016
Nov. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Sep. 30, 2014
Apr. 30, 2014
Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Unrecognized compensation cost     $ 13,807,000   $ 13,807,000        
Unrecognized compensation cost, recognition period (in years)         2 years 3 months 11 days        
Shares granted         699,820        
Stock-based compensation expense     1,988,321 $ 1,640,559 $ 3,506,482 $ 3,386,319      
Employee stock option                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock options, contractual term         10 years        
Stock-based compensation expense $ 227,000                
Performance Shares                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Unrecognized compensation cost     $ 1,000,000   $ 1,000,000        
Shares granted   150,000              
Minimum | Employee stock option                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock options, vesting period (in years)         1 year        
Maximum | Employee stock option                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock options, vesting period (in years)         4 years        
Flex Pharma, Inc. 2014 Equity Incentive Plan                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares authorized             2,070,200 1,451,087 116,754
2015 Equity Incentive Plan                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Shares remaining available for grant of stock awards     299,671   299,671